Prognia
Drug Database
🇪🇺EU · EMARefusedATC: A16Orphan Medicine

Heparesc(human heterologous liver cells)

Urea Cycle Disorders, Inborn

Marketing Authorisation Holder: Cytonet GmbH KG

INN: human heterologous liver cells

Indication

Treatment of urea cycle disorders (UCD).

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Heparesc — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.